Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States.
Saved in:
| Title: | Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States. |
|---|---|
| Authors: | Chertow GM; Departments of Medicine, Epidemiology and Population Health, and Health Policy, Stanford University School of Medicine, Stanford, California., Eckardt KU; Departments of Medicine, Epidemiology and Population Health, and Health Policy, Stanford University School of Medicine, Stanford, California., Sarnak MJ; Department of Medicine, Tufts Medical Center, Boston, Massachusetts., Winkelmayer WC; Department of Medicine, Baylor College of Medicine, Houston, Texas., Agarwal R; Department of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indiana University School of Medicine, Indianapolis, Indiana., Minga T; Akebia Therapeutics, Inc., Cambridge, Massachusetts., Luo W; Akebia Therapeutics, Inc., Cambridge, Massachusetts., Burke SK; Akebia Therapeutics, Inc., Cambridge, Massachusetts. |
| Source: | Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2025 Oct 01; Vol. 36 (10), pp. 1984-1997. Date of Electronic Publication: 2025 May 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
